Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01159353
What this trial is testing

Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 37
Early research (Phase 1)Study completedNCT00615212
What this trial is testing

Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 23
Early research (Phase 1)Study completedNCT04065581
What this trial is testing

Bioequivalence Study for Acarbose/Metformin FDC

Who this might be right for
Diabetes Mellitus, Type 2
Bayer 24
Large-scale testing (Phase 3)Study completedNCT01032629
What this trial is testing

CANVAS - CANagliflozin cardioVascular Assessment Study

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular DiseasesRisk Factors
Janssen Research & Development, LLC 4,330
Early research (Phase 1)Study completedNCT02147431
What this trial is testing

A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 38
Large-scale testing (Phase 3)Study completedNCT01698775
What this trial is testing

Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 213
Testing effectiveness (Phase 2)Study completedNCT00976495
What this trial is testing

Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 154
Early research (Phase 1)Study completedNCT01247896
What this trial is testing

Single Dose Escalation Study of PF-05190457 in Healthy Volunteers

Who this might be right for
Diabetes Mellitus, Type II
Pfizer 26
Not applicableActive Not RecruitingNCT03541096
What this trial is testing

Winter-Swimming and Brown Adipose Tissue Activity in Middel-aged Obese Subjects (WinterBAT).

Who this might be right for
Adipose Tissue, BrownBrown Adipose TissueUncoupling Protein 1+4 more
Kristian Karstoft 30
Early research (Phase 1)Study completedNCT01919684
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ligand Pharmaceuticals 56
Large-scale testing (Phase 3)Active Not RecruitingNCT06777238
What this trial is testing

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 274
Large-scale testing (Phase 3)Study completedNCT02532855
What this trial is testing

Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 614
Large-scale testing (Phase 3)Study completedNCT01318135
What this trial is testing

Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 576
Early research (Phase 1)Study completedNCT01546597
What this trial is testing

Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine

Who this might be right for
Type 2 Diabetes Mellitus
Gilead Sciences 24
Testing effectiveness (Phase 2)Ended earlyNCT00633997
What this trial is testing

Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 22
Not applicableStudy completedNCT01821846
What this trial is testing

Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 64
Not applicableStudy completedNCT06055582
What this trial is testing

To Study the Effects of Mango Ingestion in T2DM and Non-diabetic Subjects.

Who this might be right for
NormoglycemiaT2DM (Type 2 Diabetes Mellitus)
Diabetes Foundation, India 130
Early research (Phase 1)Study completedNCT02077803
What this trial is testing

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 47
Post-approval studies (Phase 4)Study completedNCT00754403
What this trial is testing

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 312
Not applicableEnrolling By InvitationNCT06895018
What this trial is testing

Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Federico II University 20
Next Page